SG/CALL/COLOPLAST B/1000/0.1/20.12.24 Stock

Warrant

DE000SU9M571

Real-time Boerse Frankfurt Warrants 09:26:25 2024-06-28 EDT
0.31 EUR +3.33% Intraday chart for SG/CALL/COLOPLAST B/1000/0.1/20.12.24
Current month+3.45%
1 month-23.08%
Date Price Change
24-06-28 0.31 +3.33%
24-06-27 0.3 -9.09%
24-06-26 0.33 0.00%
24-06-25 0.33 0.00%
24-06-24 0.33 -2.94%

Real-time Boerse Frankfurt Warrants

Last update June 28, 2024 at 09:26 am

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying COLOPLAST A/S
IssuerLogo Issuer Société Générale Société Générale
WKN SU9M57
ISINDE000SU9M571
Date issued 2024-02-21
Strike 1,000 kr
Maturity 2024-12-20 (175 Days)
Parity 10 : 1
Emission price 1.8
Emission volume N/A
Settlement Por diferencias
Currency EUR

Technical Indicators

Highest since issue 1.33
Lowest since issue 0.25
Delta0x
Omega 0.000000
Premium0x
Gearing35.03x
Moneyness 0.8368
Difference Strike 161 kr
Difference Strike %+16.10%
Spread 0.02
Spread %6.06%
Intrinsic value 0.000000
Present value 0.3200

Company Profile

Coloplast A/S specializes in the design, manufacturing, and marketing of disposable medical products. Net sales break down by family of products as follows: - hygiene products (43.4%): urine bags, plugs, urinary testing systems and sets, etc.; - ostomy care products (36.8%): bags and equipment used following intestinal operations; - wound care and skincare products (11.9%): wound dressings, bandages, creams and gels; - voice and respiratory care products (7.9%): voice prostheses for speaking, adhesives, laryngectomy cannulas for breathing, hands-free speaking devices, etc. Net sales are distributed geographically as follows: Denmark (1.4%), the United States (21%), the United Kingdom (14%), France (10.8%) and other (52.8%).
Sector
-
More about the company

Ratings for Coloplast A/S

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Consensus: Coloplast A/S

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
20
Last Close Price
840.4 DKK
Average target price
895.4 DKK
Spread / Average Target
+6.54%
Consensus